<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Multiple vitamins (injectable): Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Multiple vitamins (injectable): Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Multiple vitamins (injectable): Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="12155" href="/d/html/12155.html" rel="external">see "Multiple vitamins (injectable): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F234608"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Infuvite Adult;</li>
<li>Infuvite Pediatric</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F234618"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Vitamin</li></ul></div>
<div class="block doa drugH1Div" id="F234609"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="81863c66-ac4f-45ff-b638-ded564c6efe2">Dietary supplement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dietary supplement:</b>
<b>IV:</b> Adult formulation: 10 mL/day added to ≥500 mL of parenteral nutrition or appropriate solution.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F56592120"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling (has not been studied); use with caution.</p></div>
<div class="block doha drugH1Div" id="F56592121"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling (has not been studied); use with caution.</p></div>
<div class="block doe drugH1Div" id="F234610"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F234615"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="81863c66-ac4f-45ff-b638-ded564c6efe2">Dietary supplement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dietary supplement:</b> IV:</p>
<p style="text-indent:-2em;margin-left:4em;">Infants &lt;1 kg: Pediatric formulation: 1.5 mL/day added to TPN or ≥100 mL of appropriate solution (maximum: 1.5 mL/day)</p>
<p style="text-indent:-2em;margin-left:4em;">Infants 1 to 3 kg: Pediatric formulation: 3.25 mL/day added to TPN or ≥100 mL of appropriate solution. Multiples of this dose should not be given to infants weighing &lt;3 kg.</p>
<p style="text-indent:-2em;margin-left:4em;">Infants ≥3 kg and Children &lt;11 years: Pediatric formulation: 5 mL/day added to TPN or ≥100 mL of appropriate solution</p>
<p style="text-indent:-2em;margin-left:4em;">Children ≥11 years and Adolescents: Adult formulation: Refer to adult dosing.</p></div>
</div>
</div>
<div class="block adr drugH1Div" id="F234592"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Frequency not defined.</p>
<p style="text-indent:-2em;margin-left:2em;">Cardiovascular: Edema</p>
<p style="text-indent:-2em;margin-left:2em;">Central nervous system: Agitation, anxiety, dizziness, headache</p>
<p style="text-indent:-2em;margin-left:2em;">Dermatologic: Erythema, pruritus, skin rash, urticaria</p>
<p style="text-indent:-2em;margin-left:2em;">Endocrine &amp; metabolic: Hypervitaminosis</p>
<p style="text-indent:-2em;margin-left:2em;">Hypersensitivity: Anaphylaxis, angioedema, hypersensitivity reaction</p>
<p style="text-indent:-2em;margin-left:2em;">Ophthalmic: Diplopia</p>
<p style="text-indent:-2em;margin-left:2em;">Respiratory: Dyspnea, wheezing</p></div>
<div class="block coi drugH1Div" id="F234602"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to any component of the formulation; preexisting hypervitaminosis</p></div>
<div class="block war drugH1Div" id="F234590"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects: </i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Hypersensitivity reactions: Allergic reactions, including urticaria, shortness of breath, wheezing, and angioedema, have been reported following parenteral doses of thiamine; anaphylaxis has also been reported (rare).</p>
<p style="text-indent:-2em;margin-left:4em;">• Hypervitaminosis A: Has been reported in patients with renal failure receiving 1.6 mg/day of retinol and in patients with liver disease; use with caution.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Hepatic impairment: Use with caution in patients with hepatic impairment.</p>
<p style="text-indent:-2em;margin-left:4em;">• Megaloblastic anemia: Do not use prior to blood testing for megaloblastic anemia.</p>
<p style="text-indent:-2em;margin-left:4em;">• Renal impairment: Use with caution in patients with renal impairment.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concurrent drug therapy issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Anticoagulants: Some formulations may contain vitamin K, which may reduce the effectiveness of vitamin K-dependent anticoagulants (eg, warfarin); periodically monitor PT/INR in these patients.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register 2002). See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Polysorbates: Some formulations may contain polysorbates which have been associated with the E-Ferol syndrome (thrombocytopenia, renal impairment, hepatomegaly, cholestasis, ascites, hypotension, metabolic acidosis) in low birth weight infants.</p>
<p style="text-indent:-2em;margin-left:4em;">• Vitamin A: May adhere to plastic, resulting in inadequate vitamin A concentrations after administration. Additional vitamin A supplementation may be required, especially in low birth weight infants.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Laboratory test interference: Biotin in blood or other samples taken from patients who are ingesting high levels of biotin from dietary supplements (including multivitamins; prenatal multivitamins; biotin supplements; and dietary supplements for hair, skin, and nail growth) can cause clinically significant incorrect lab test results. Some testing methods use biotin technology (eg, troponin, hormone tests), using biotin to bind to specific proteins that are measured to detect health conditions. An increase in the number of reported adverse events, including one death, related to biotin interference with lab tests has been reported. If a lab test result does not correspond with a patient's clinical symptoms, biotin interference should be considered as a possible source of error (FDA Safety Communication 2017).</p></div>
<div class="block foc drugH1Div" id="F234597"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">Content varies depending on product used. For more detailed information on ingredients in these and other multivitamins, please refer to <b>specific product labeling</b>.</p></div>
<div class="block geq drugH1Div" id="F234587"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block adm drugH1Div" id="F234600"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">IV: For IV use only (not for direct infusion); solution must be diluted prior to administration.</p></div>
<div class="block admp drugH1Div" id="F52614014"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">IV: Not for direct IV injection; must be diluted prior to administration; direct administration of solution may cause tissue irritation, dizziness, and fainting.</p></div>
<div class="block use drugH1Div" id="F234598"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Dietary supplement:</b> Nutritional supplement in patients receiving parenteral nutrition or requiring intravenous administration</p></div>
<div class="block pri drugH1Div" id="F234603"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Refer to individual vitamin monographs for requirements during pregnancy.</p></div>
<div class="block brc drugH1Div" id="F14191358"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">Refer to individual vitamin monographs for requirements while breastfeeding.</p></div>
<div class="block mop drugH1Div" id="F51451730"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Blood vitamin concentrations periodically; renal function tests, calcium, phosphorus, and vitamin A levels in patients with renal impairment; vitamin A levels in patients with hepatic impairment or excessive alcohol consumption.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58844315"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Cernevit</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793. To be codified at 21 CFR §201.323.</div>
</li>
<li>
<div class="reference">
                  Food and Drug Administration. The FDA warns that biotin may interfere with lab tests: FDA safety communication. <a href="https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm586505.htm" target="_blank">https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm586505.htm</a>. Accessed November 20, 2018.</div>
</li>
<li>
<div class="reference">
                  Infuvite Adult (multi-vitamin injection) [prescribing information]. Deerfield, IL: Baxter Healthcare Corporation; October 2016.</div>
</li>
<li>
<div class="reference">
                  M.V.I.-Adult (multi-vitamin injection) [prescribing information]. Lake Forest, IL: Hospira Inc; November 2017.</div>
</li>
<li>
<div class="reference">
                  M.V.I. Pediatric (multivitamin injection) [prescribing information]. Lake Forest, IL: Hospira Inc; February 2019.</div>
</li></ol></div><div id="topicVersionRevision">Topic 10314 Version 97.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
